CH ENV TECH&BIO (01237) released annual performance data, with a net profit of 44.701 million yuan, a year-on-year increase of 1398.52%.

22:08 31/03/2026

China Biotech (01237) announced its annual performance for the year ending December 31, 2025. The Group's revenue was 479.5 million yuan, a year-on-year increase of 17.07%; net profit was 44.701 million yuan, a year-on-year increase of 1398.52%; earnings per share were 0.48 yuan.

CH ENV TECH&BIO (01237) released its annual performance figures for the year ending December 31, 2025, with a total revenue of 479.5 million yuan, an increase of 17.07% year-on-year; a net profit of 447.01 million yuan, an increase of 1398.52% year-on-year; and earnings per share of 0.48 yuan.

FW FASHION INT (02528) releases annual performance, with a net profit attributable to shareholders of HK$ 57.673 million, turning losses into profits on a year-on-year basis.

INGDAN (00400) announced its performance for 2025, with a net profit attributable to shareholders of approximately 215 million yuan, an increase of 13.1% year-on-year.

MEDSCI (02415) released its annual performance, with a net profit attributable to shareholders of 1793.7 million yuan, a decrease of 28.16% compared to the previous year.

FW FASHION INT (02528) releases annual performance, with a net profit attributable to shareholders of HK$ 57.673 million, turning losses into profits on a year-on-year basis.

INGDAN (00400) announced its performance for 2025, with a net profit attributable to shareholders of approximately 215 million yuan, an increase of 13.1% year-on-year.

MEDSCI (02415) released its annual performance, with a net profit attributable to shareholders of 1793.7 million yuan, a decrease of 28.16% compared to the previous year.